1371 results

Certara Earns 2022 Great Place to Work Certification™

Princeton, NJ, May 17, 2022.  Certara, Inc., a global leader in biosimulation, today announced that the Company was Certified™ by Great Place to Work® in its first year of participation.  The prestigious award is based entirely on what current employees say about their experience working at Certara. This year, 88% of employees said it’s a … Continued


FDA Posts Final Guidance for the Electronic Submission of Post-marketing Safety Reports

For just a few seconds, I want you to close your eyes and take a deep breath. Exhale. Now picture yourself at work in the regulatory operations and safety department of a biopharmaceutical company. It is 5:20 PM, and you and another colleague are headed out of the door for the day. You both wanted … Continued


Ask Me Anything: Career Opportunities in Regulatory & Medical Writing

June 8, 2022 – 11am ET Have you ever wondered what it would be like to be a Regulatory or Medical Writer in the pharmaceutical industry? Certara’s global regulatory writing team includes PhDs, MDs, PharmDs, scientists, and nurses with backgrounds across all functional areas (Document Quality, CMC, Nonclinical, Clinical, and Regulatory). Our team is growing, … Continued


2022 Page Soccer Tournament

Date: June 29th 2022Duration: 18.00 – 21.00Maximum number of participants: ~160Venue: Sports Center Šiška Certara is excited to bring this annual tradition back this year. Registration is through the PAGE conference, open to conference attendees at no additional charge. The tournament will take place on the evening of Wednesday June 29th. Registration closes on June … Continued


Approaches to Address the Regulatory Requirements for System Qualification of the Simcyp Simulator

Physiologically-based pharmacokinetic (PBPK) modeling is being increasingly used in drug development to avoid unnecessary clinical drug–drug interaction (DDI) studies and inform drug labels. Thus, regulatory agencies are recommending more rigorous demonstration of the prediction accuracy of PBPK platforms in their intended use.  During the webinar, we will present a framework for qualification of the Simcyp … Continued


Certara Reports First Quarter 2022 Financial Results

PRINCETON, N.J.—May 5, 2022– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2022. First Quarter Highlights: Revenue was $81.6 million, compared to $66.7 million in the first quarter of 2021, representing growth of 22% over the first quarter of 2021. Excluding Pinnacle … Continued

1 of 138
Back to top